Adistem Pops the Fat Stem Cell Cork In France

Printer-friendly versionPDF version

Hong Kong – Biotechnology company Adistem has unveiled a new study at a medical conference in France that shows promise in helping Type II diabetics through the use of the patient’s own fat stem cells.

Bangkok, Thailand (PressReleasePoint) November 13,2008 -- Adistem, working with Dr. Bill Paspaliaris, conducted a nine-month study involving 37 diabetics and developed a medical method to activate dormant stem cells stored in body fat.

Adistem’s technology separates fat stem cells from a patient’s own fat, moves it into a test tube, then adds an activator solution. The activated cells are then given back to the patient and they begin to repair the body.

Paspaliaris presented the study in Toulouse, France at the IFATS Conference – a group of researchers working on fat stem cell technology and medical applications. More than 1,500 papers were submitted and Paspaliaris’ study was one of only 15 chosen for presentation.

"We are very pleased at the progress and the scientific community's response to Dr. BIll Paspaliaris' presentation in Toulouse, France," says Brian Dardzinski, CEO of Regenerative Medicine International, a company that finds patients around the world the best stem cell-related health care.

“This has increased interest from hospitals and doctors in the Asian region, as clinical trials are being conducted with the Adistem technology in Thailand," Dardzinski says.

Stem cells are the master cells that control the body's repair and regeneration of damaged tissues. Diseases such as diabetes, multiple sclerosis, and cerebral palsy are all being successfully treated with stem cells.

About Adistem

Adistem is a biotechnology company that discovers, develops and provides to licensed doctors autologous adult adipose-derived stem cell products that address serious medical conditions and assist, in particular, cosmetic and plastic surgery procedures. Adistem owns proprietary technologies that are licensed to major hospitals and world-class clinics.

About Regenerative Medicine International
Regenerative Medicine International is dedicated to helping early stage stem cell technology companies commercialize in the Asian market. With offices in Hong Kong and Bangkok, Thailand, RMI and its staff assist hospitals and doctors with Regenerative Medicine Technologies aimed at improving the lives of patients. RMI works with premier hospitals and clinics in Asia to assist in marketing and distribution of cellular medicine. The company also provides a patient portal www.returninghope.com, to act as a resource for people seeking stem cell therapy anywhere in the world.

Company: Regenerative Medicine International
Email: bdardzinski@returninghope.com
Phone: (66) 26558118
Website: http://www.returninghope.com